The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.

Source:http://linkedlifedata.com/resource/pubmed/id/21907923

Cancer Cell 2011 Sep 13 20 3 315-27

Download in:

View as

General Info

PMID
21907923